Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An External Control, Observational, Retrospective Study Assessing the Effect of Pralsetinib Compared With Best Available Therapy for Patients With RET-Fusion Positive Advanced Non-Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04697446
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:04.356638+00:00
Published At
2021-08-10T00:00:00+00:00
Record Updated At
2021-08-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["RET-fusion Non Small Cell Lung Cancer", "Lung Neoplasm", "Carcinoma, Non-Small-Cell Lung", "Respiratory Tract Neoplasms", "Thoracic Neoplasms", "Neoplasms by Site", "Neoplasms", "Lung Diseases", "Respiratory Tract Diseases", "Carcinoma, Bronchogenic", "Bronchial Diseases", "Head and Neck Neoplasms", "Carcinoma", "Neoplasms by Histologic Type", "Neoplasms, Germ Cell and Embryonal", "Neoplasms, Nerve Tissue", "Metastatic Non Small Cell Lung Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-08-10"
protocolSection.identificationModule.nctId
"NCT04697446"
protocolSection.identificationModule.officialTitle
"An External Control, Observational, Retrospective Study Assessing the Effect of Pralsetinib Compared With Best Available Therapy for Patients With RET-Fusion Positive Advanced Non-Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • RET-fusion Non Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Lung Neoplasm (protocolSection.conditionsModule.conditions)
  • Carcinoma, Non-Small-Cell Lung (protocolSection.conditionsModule.conditions)
  • Respiratory Tract Neoplasms (protocolSection.conditionsModule.conditions)
  • Thoracic Neoplasms (protocolSection.conditionsModule.conditions)
  • Neoplasms by Site (protocolSection.conditionsModule.conditions)
  • Neoplasms (protocolSection.conditionsModule.conditions)
  • Lung Diseases (protocolSection.conditionsModule.conditions)
  • Respiratory Tract Diseases (protocolSection.conditionsModule.conditions)
  • Carcinoma, Bronchogenic (protocolSection.conditionsModule.conditions)
  • Bronchial Diseases (protocolSection.conditionsModule.conditions)
  • Head and Neck Neoplasms (protocolSection.conditionsModule.conditions)
  • Carcinoma (protocolSection.conditionsModule.conditions)
  • Neoplasms by Histologic Type (protocolSection.conditionsModule.conditions)
  • Neoplasms, Germ Cell and Embryonal (protocolSection.conditionsModule.conditions)
  • Neoplasms, Nerve Tissue (protocolSection.conditionsModule.conditions)
  • Metastatic Non Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.